<DOC>
	<DOCNO>NCT01641900</DOCNO>
	<brief_summary>The investigator test hypothesis sleep medication , eszopiclone , normalize brain activity sleep improve memory patient schizophrenia . The investigator compare sleep performance participant take eszopiclone participant take placebo . The investigator study healthy subject patient schizophrenia take atypical antipsychotic medication .</brief_summary>
	<brief_title>Effects Eszopiclone Sleep Memory Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>clinically stable outpatient schizophrenia , proficient English , able give inform consent , maintain stable dose atypical antipsychotic medication least 6 week prior enrollment . healthy Control participant match group patient age , sex , parental socioeconomic status . Substance abuse dependence within past six month ; chronic medical condition affect sleep ; ( pregnancy/breast feeding ; hepatic impairment ; treatment inhibitor inducer CYP 3A4 2E1 enzyme ( metabolize eszopiclone ) ; history head injury result prolonged loss consciousness neurological sequela ; ( mental retardation ; ( diagnosed sleep disorder insomnia , neurological disorder ; sleep disorder , insomnia , identify clinical sleep evaluation . Patients conventional agent , benzodiazepine , sleep agent exclude . Potential control excluded personal history mental illness , family history schizophrenia spectrum disorder psychosis , treatment medication know affect sleep cognition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>sleep</keyword>
	<keyword>memory</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>eszopiclone</keyword>
</DOC>